Selpercatinib + Mao Inhibitors Interaction
Moderateinteraction on record
Description
Concomitant use decreases selpercatinib plasma concentrations, which may reduce anti-tumor activity. Avoid coadministration; if unavoidable, take RETEVMO with food.
Mechanism
Acid-reducing agents decrease selpercatinib absorption
Source: NLP:selpercatinib